NR667 VISE EXAM STUDY GUIDE | Chamberlain
FNP Capstone | Verified Questions and Answers |
Pass Guaranteed - A+ Graded
Question 1: An FNP student is preparing for the NR667 Virtual Integrated Simulation Experience (VISE)
capstone call and gathers required equipment including an ophthalmoscope, otoscope, reflex hammer,
pocket Snellen chart, and a stethoscope with diaphragm and bell. Which additional item is explicitly
required during the live faculty simulation?
A. A full 12-lead electrocardiogram machine and gel
B. A clinical pharmacology reference text and paper/pencil for clinical notes
C. A complete digital rectal examination kit with lubricant and gloves
D. A point-of-care comprehensive metabolic panel testing device
CORRECT ANSWER: B. A clinical pharmacology reference text and paper/pencil for clinical notes
Rationale: Per the Chamberlain University NR667 VISE guidelines, students must have paper and a
writing utensil for documentation along with a reliable clinical pharmacology reference to safely verify
dosages and pharmacological agents when formulating management plans during the live evaluation.
Specialized equipment like 12-lead ECG machines or digital rectal kits are not required or expected
during the remote telehealth simulation encounter.
Question 2: During the NR667 VISE evaluation, a faculty member presents a clinical scenario involving a
54-year-old male with an office blood pressure reading consistently averaging 148/92 mmHg over
multiple visits, with no acute target organ damage. According to evidence-based FNP guidelines, what is
the most appropriate first-line pharmacologic management option for this patient?
A. Hydrochlorothiazide 25 mg orally once daily
B. Atenolol 50 mg orally once daily
C. Clonidine 0.1 mg transdermally weekly
D. Hydralazine 50 mg orally three times daily
CORRECT ANSWER: A. Hydrochlorothiazide 25 mg orally once daily
Rationale: For uncomplicated hypertension with a blood pressure greater than 140/90 mmHg, first-line
pharmacologic options include thiazide diuretics (such as hydrochlorothiazide 25 mg daily), calcium
channel blockers (such as amlodipine), or ACE inhibitors/ARBs. Atenolol is a beta-blocker and is no longer
,recommended as first-line uncomplicated hypertension therapy per current guidelines. Hydralazine and
clonidine are not first-line agents due to adverse effect profiles and reflex tachycardia or rebound
hypertension risks.
Question 3: A 45-year-old female presents to the clinic for routine evaluation, and laboratory results
reveal a fasting low-density lipoprotein (LDL) cholesterol level of 195 mg/dL. Based on standard clinical
guidelines emphasized in the FNP capstone curriculum, what is the appropriate initial management
strategy?
A. Diet and exercise counseling alone with a 1-year follow-up lipid panel
B. Initiation of moderate-intensity statin therapy (e.g., Atorvastatin 10 mg daily) alongside lifestyle
modifications
C. Immediate referral for LDL apheresis and therapeutic plasma exchange
D. Prescription of immediate-release niacin monotherapy without baseline liver function tests
CORRECT ANSWER: B. Initiation of moderate-intensity statin therapy (e.g., Atorvastatin 10 mg daily)
alongside lifestyle modifications
Rationale: Patients presenting with a primary severe LDL elevation of 190 mg/dL or greater require
immediate statin therapy (such as atorvastatin 10 mg daily) in addition to comprehensive lifestyle
modifications (diet and exercise) regardless of 10-year ASCVD risk scores. Waiting a full year with lifestyle
modifications alone is insufficient for severe hyperlipidemia, and niacin is no longer routinely
recommended as first-line therapy due to lack of cardiovascular event reduction benefit and adverse
effects.
Question 4: A 62-year-old male with a history of type 2 diabetes mellitus presents for a routine follow-up.
His home blood glucose logs show fasting values consistently between 135-150 mg/dL, and his HbA1c is
8.2%. He currently takes Metformin 1000 mg twice daily. Which medication is appropriate to add to his
regimen to address postprandial and fasting hyperglycemia while minimizing hypoglycemia risk?
A. Regular insulin infusion pump therapy
B. Pioglitazone (Actos) 15 mg orally daily
C. Glyburide 20 mg orally twice daily
D. Glimepiride 8 mg orally twice daily
CORRECT ANSWER: B. Pioglitazone (Actos) 15 mg orally daily
Rationale: Thiazolidinediones like pioglitazone (Actos) can be safely added to metformin when glycemic
control is suboptimal, starting at 15 mg daily. High-dose sulfonylureas like glyburide or glimepiride carry
a significant risk of severe hypoglycemia, particularly in older adults, and starting at maximal doses is
,unsafe. Immediate initiation of insulin pump therapy is unwarranted prior to optimizing oral combination
therapy and lifestyle interventions.
Question 5: A 32-year-old female presents with acute onset sore throat, fever of 101.2 F, tender anterior
cervical lymphadenopathy, and pharyngeal erythema with tonsillar exudates. She denies cough.
Following Centor criteria clinical decision rules, what is the next best clinical step?
A. Immediately prescribe broad-spectrum intravenous ceftriaxone
B. Perform a rapid antigen detection test (RADT) and/or throat culture, treating empirically with penicillin
or amoxicillin only if positive
C. Reassure the patient that this is viral rhinopharyngitis and discharge without testing
D. Order a stat CT scan of the soft tissue neck for deep space abscess evaluation
CORRECT ANSWER: B. Perform a rapid antigen detection test (RADT) and/or throat culture, treating
empirically with penicillin or amoxicillin only if positive
Rationale: A patient presenting with fever, tender anterior cervical lymphadenopathy, tonsillar exudates,
and absence of cough scores 4 on the Centor criteria, indicating a high probability of Group A beta-
hemolytic Streptococcus (GABHS). Current evidence-based guidelines recommend diagnostic
confirmation via rapid antigen test or throat culture prior to initiating targeted antibiotic therapy such as
penicillin or amoxicillin. Empirical broad-spectrum IV antibiotics or advanced imaging are unnecessary
for uncomplicated pharyngitis.
Question 6: A 28-year-old female presents with recurrent sneezing, nasal congestion, and clear
rhinorrhea that worsens every spring when pollen counts rise. Physical exam reveals pale, edematous
nasal turbinates and clear nasal secretions. What is the most effective first-line pharmacologic treatment
for persistent allergic rhinitis?
A. Oral diphenhydramine 50 mg every 6 hours as needed
B. Intranasal corticosteroid spray (e.g., fluticasone propionate)
C. Daily oral pseudoephedrine 60 mg indefinitely
D. Topical oxymetazoline nasal spray for 30 consecutive days
CORRECT ANSWER: B. Intranasal corticosteroid spray (e.g., fluticasone propionate)
Rationale: Intranasal corticosteroid sprays are the most potent and effective first-line pharmacologic
therapy for allergic rhinitis, controlling sneezing, congestion, and rhinorrhea. First-generation
antihistamines like diphenhydramine cause significant sedation and anticholinergic side effects. Oral
decongestants like pseudoephedrine should be used cautiously due to cardiovascular side effects, and
, topical oxymetazoline must not be used for more than 3 to 5 consecutive days due to the severe risk of
rhinitis medicamentosa (rebound congestion).
Question 7: A 50-year-old male presents with chronic, burning epigastric pain that worsens after meals
and when lying flat, accompanied by a sour taste in his mouth. He has tried over-the-counter antacids
with minimal relief. What is the most appropriate initial diagnostic or therapeutic approach for suspected
gastroesophageal reflux disease (GERD)?
A. Immediate diagnostic upper endoscopy (EGD) on the first visit
B. A 4-to-8-week trial of once-daily proton pump inhibitor (PPI) therapy (e.g., omeprazole 20 mg daily)
C. Barium swallow radiography as the definitive gold standard test
D. 24-hour ambulatory esophageal manometry and pH monitoring
CORRECT ANSWER: B. A 4-to-8-week trial of once-daily proton pump inhibitor (PPI) therapy (e.g.,
omeprazole 20 mg daily)
Rationale: For typical uncomplicated GERD symptoms, an empiric 4-to-8-week trial of a once-daily
proton pump inhibitor is the standard initial diagnostic and therapeutic strategy. Upper endoscopy (EGD)
is reserved for patients with alarm symptoms (dysphagia, weight loss, bleeding, anemia) or those who
fail an adequate trial of medical therapy. Barium swallow is insensitive for mucosal inflammation, and
ambulatory pH monitoring is utilized for refractory symptoms before surgical intervention.
Question 8: A 68-year-old male presents with progressive urinary hesitancy, a weak urinary stream,
nocturia waking him 4 times per night, and a sensation of incomplete bladder emptying. Digital rectal
exam reveals a uniformly enlarged, firm, non-tender, smooth prostate gland. Urinalysis is completely
negative. What is the most likely diagnosis and first-line medical management?
A. Prostatitis; fluoroquinolone antibiotics for 6 weeks
B. Benign Prostatic Hyperplasia (BPH); an alpha-1 blocker such as tamsulosin
C. Prostate adenocarcinoma; immediate surgical prostatectomy
D. Overactive bladder; a strong anticholinergic agent like oxybutynin monotherapy
CORRECT ANSWER: B. Benign Prostatic Hyperplasia (BPH); an alpha-1 blocker such as tamsulosin
Rationale: The classic presentation of obstructive lower urinary tract symptoms combined with a
smooth, symmetrical, enlarged prostate on DRE points directly to Benign Prostatic Hyperplasia (BPH).
First-line medical therapy for moderate symptoms includes alpha-1 adrenergic antagonists (e.g.,
tamsulosin) which relax smooth muscle in the bladder neck and prostate. Antibiotics are reserved for
prostatitis, and anticholinergics alone can precipitate acute urinary retention in uninvestigated severe
BPH obstruction.
FNP Capstone | Verified Questions and Answers |
Pass Guaranteed - A+ Graded
Question 1: An FNP student is preparing for the NR667 Virtual Integrated Simulation Experience (VISE)
capstone call and gathers required equipment including an ophthalmoscope, otoscope, reflex hammer,
pocket Snellen chart, and a stethoscope with diaphragm and bell. Which additional item is explicitly
required during the live faculty simulation?
A. A full 12-lead electrocardiogram machine and gel
B. A clinical pharmacology reference text and paper/pencil for clinical notes
C. A complete digital rectal examination kit with lubricant and gloves
D. A point-of-care comprehensive metabolic panel testing device
CORRECT ANSWER: B. A clinical pharmacology reference text and paper/pencil for clinical notes
Rationale: Per the Chamberlain University NR667 VISE guidelines, students must have paper and a
writing utensil for documentation along with a reliable clinical pharmacology reference to safely verify
dosages and pharmacological agents when formulating management plans during the live evaluation.
Specialized equipment like 12-lead ECG machines or digital rectal kits are not required or expected
during the remote telehealth simulation encounter.
Question 2: During the NR667 VISE evaluation, a faculty member presents a clinical scenario involving a
54-year-old male with an office blood pressure reading consistently averaging 148/92 mmHg over
multiple visits, with no acute target organ damage. According to evidence-based FNP guidelines, what is
the most appropriate first-line pharmacologic management option for this patient?
A. Hydrochlorothiazide 25 mg orally once daily
B. Atenolol 50 mg orally once daily
C. Clonidine 0.1 mg transdermally weekly
D. Hydralazine 50 mg orally three times daily
CORRECT ANSWER: A. Hydrochlorothiazide 25 mg orally once daily
Rationale: For uncomplicated hypertension with a blood pressure greater than 140/90 mmHg, first-line
pharmacologic options include thiazide diuretics (such as hydrochlorothiazide 25 mg daily), calcium
channel blockers (such as amlodipine), or ACE inhibitors/ARBs. Atenolol is a beta-blocker and is no longer
,recommended as first-line uncomplicated hypertension therapy per current guidelines. Hydralazine and
clonidine are not first-line agents due to adverse effect profiles and reflex tachycardia or rebound
hypertension risks.
Question 3: A 45-year-old female presents to the clinic for routine evaluation, and laboratory results
reveal a fasting low-density lipoprotein (LDL) cholesterol level of 195 mg/dL. Based on standard clinical
guidelines emphasized in the FNP capstone curriculum, what is the appropriate initial management
strategy?
A. Diet and exercise counseling alone with a 1-year follow-up lipid panel
B. Initiation of moderate-intensity statin therapy (e.g., Atorvastatin 10 mg daily) alongside lifestyle
modifications
C. Immediate referral for LDL apheresis and therapeutic plasma exchange
D. Prescription of immediate-release niacin monotherapy without baseline liver function tests
CORRECT ANSWER: B. Initiation of moderate-intensity statin therapy (e.g., Atorvastatin 10 mg daily)
alongside lifestyle modifications
Rationale: Patients presenting with a primary severe LDL elevation of 190 mg/dL or greater require
immediate statin therapy (such as atorvastatin 10 mg daily) in addition to comprehensive lifestyle
modifications (diet and exercise) regardless of 10-year ASCVD risk scores. Waiting a full year with lifestyle
modifications alone is insufficient for severe hyperlipidemia, and niacin is no longer routinely
recommended as first-line therapy due to lack of cardiovascular event reduction benefit and adverse
effects.
Question 4: A 62-year-old male with a history of type 2 diabetes mellitus presents for a routine follow-up.
His home blood glucose logs show fasting values consistently between 135-150 mg/dL, and his HbA1c is
8.2%. He currently takes Metformin 1000 mg twice daily. Which medication is appropriate to add to his
regimen to address postprandial and fasting hyperglycemia while minimizing hypoglycemia risk?
A. Regular insulin infusion pump therapy
B. Pioglitazone (Actos) 15 mg orally daily
C. Glyburide 20 mg orally twice daily
D. Glimepiride 8 mg orally twice daily
CORRECT ANSWER: B. Pioglitazone (Actos) 15 mg orally daily
Rationale: Thiazolidinediones like pioglitazone (Actos) can be safely added to metformin when glycemic
control is suboptimal, starting at 15 mg daily. High-dose sulfonylureas like glyburide or glimepiride carry
a significant risk of severe hypoglycemia, particularly in older adults, and starting at maximal doses is
,unsafe. Immediate initiation of insulin pump therapy is unwarranted prior to optimizing oral combination
therapy and lifestyle interventions.
Question 5: A 32-year-old female presents with acute onset sore throat, fever of 101.2 F, tender anterior
cervical lymphadenopathy, and pharyngeal erythema with tonsillar exudates. She denies cough.
Following Centor criteria clinical decision rules, what is the next best clinical step?
A. Immediately prescribe broad-spectrum intravenous ceftriaxone
B. Perform a rapid antigen detection test (RADT) and/or throat culture, treating empirically with penicillin
or amoxicillin only if positive
C. Reassure the patient that this is viral rhinopharyngitis and discharge without testing
D. Order a stat CT scan of the soft tissue neck for deep space abscess evaluation
CORRECT ANSWER: B. Perform a rapid antigen detection test (RADT) and/or throat culture, treating
empirically with penicillin or amoxicillin only if positive
Rationale: A patient presenting with fever, tender anterior cervical lymphadenopathy, tonsillar exudates,
and absence of cough scores 4 on the Centor criteria, indicating a high probability of Group A beta-
hemolytic Streptococcus (GABHS). Current evidence-based guidelines recommend diagnostic
confirmation via rapid antigen test or throat culture prior to initiating targeted antibiotic therapy such as
penicillin or amoxicillin. Empirical broad-spectrum IV antibiotics or advanced imaging are unnecessary
for uncomplicated pharyngitis.
Question 6: A 28-year-old female presents with recurrent sneezing, nasal congestion, and clear
rhinorrhea that worsens every spring when pollen counts rise. Physical exam reveals pale, edematous
nasal turbinates and clear nasal secretions. What is the most effective first-line pharmacologic treatment
for persistent allergic rhinitis?
A. Oral diphenhydramine 50 mg every 6 hours as needed
B. Intranasal corticosteroid spray (e.g., fluticasone propionate)
C. Daily oral pseudoephedrine 60 mg indefinitely
D. Topical oxymetazoline nasal spray for 30 consecutive days
CORRECT ANSWER: B. Intranasal corticosteroid spray (e.g., fluticasone propionate)
Rationale: Intranasal corticosteroid sprays are the most potent and effective first-line pharmacologic
therapy for allergic rhinitis, controlling sneezing, congestion, and rhinorrhea. First-generation
antihistamines like diphenhydramine cause significant sedation and anticholinergic side effects. Oral
decongestants like pseudoephedrine should be used cautiously due to cardiovascular side effects, and
, topical oxymetazoline must not be used for more than 3 to 5 consecutive days due to the severe risk of
rhinitis medicamentosa (rebound congestion).
Question 7: A 50-year-old male presents with chronic, burning epigastric pain that worsens after meals
and when lying flat, accompanied by a sour taste in his mouth. He has tried over-the-counter antacids
with minimal relief. What is the most appropriate initial diagnostic or therapeutic approach for suspected
gastroesophageal reflux disease (GERD)?
A. Immediate diagnostic upper endoscopy (EGD) on the first visit
B. A 4-to-8-week trial of once-daily proton pump inhibitor (PPI) therapy (e.g., omeprazole 20 mg daily)
C. Barium swallow radiography as the definitive gold standard test
D. 24-hour ambulatory esophageal manometry and pH monitoring
CORRECT ANSWER: B. A 4-to-8-week trial of once-daily proton pump inhibitor (PPI) therapy (e.g.,
omeprazole 20 mg daily)
Rationale: For typical uncomplicated GERD symptoms, an empiric 4-to-8-week trial of a once-daily
proton pump inhibitor is the standard initial diagnostic and therapeutic strategy. Upper endoscopy (EGD)
is reserved for patients with alarm symptoms (dysphagia, weight loss, bleeding, anemia) or those who
fail an adequate trial of medical therapy. Barium swallow is insensitive for mucosal inflammation, and
ambulatory pH monitoring is utilized for refractory symptoms before surgical intervention.
Question 8: A 68-year-old male presents with progressive urinary hesitancy, a weak urinary stream,
nocturia waking him 4 times per night, and a sensation of incomplete bladder emptying. Digital rectal
exam reveals a uniformly enlarged, firm, non-tender, smooth prostate gland. Urinalysis is completely
negative. What is the most likely diagnosis and first-line medical management?
A. Prostatitis; fluoroquinolone antibiotics for 6 weeks
B. Benign Prostatic Hyperplasia (BPH); an alpha-1 blocker such as tamsulosin
C. Prostate adenocarcinoma; immediate surgical prostatectomy
D. Overactive bladder; a strong anticholinergic agent like oxybutynin monotherapy
CORRECT ANSWER: B. Benign Prostatic Hyperplasia (BPH); an alpha-1 blocker such as tamsulosin
Rationale: The classic presentation of obstructive lower urinary tract symptoms combined with a
smooth, symmetrical, enlarged prostate on DRE points directly to Benign Prostatic Hyperplasia (BPH).
First-line medical therapy for moderate symptoms includes alpha-1 adrenergic antagonists (e.g.,
tamsulosin) which relax smooth muscle in the bladder neck and prostate. Antibiotics are reserved for
prostatitis, and anticholinergics alone can precipitate acute urinary retention in uninvestigated severe
BPH obstruction.
